Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand

被引:1
作者
Permsuwan, Unchalee [1 ]
Phrommintikul, Arintaya [2 ]
Silavanich, Voratima [1 ]
机构
[1] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Suthep Rd, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai, Thailand
来源
CLINICOECONOMICS AND OUTCOMES RESEARCH | 2020年 / 12卷
关键词
cost-effectiveness; quality-adjusted life-years; cardiac resynchronization therapy; heart failure; Thailand; MORTALITY; DEFIBRILLATOR; DEATH;
D O I
10.2147/CEOR.S268553
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Cardiac resynchronization therapy (CRT) improves symptoms and survival in patients with heart failure (HF). However, the CRT devices are costly and can impose a significant burden to the relatively constrained health budgets of middle-income countries such as Thailand. The aim of this study was to analyze the cost-effectiveness of CRT in combination with optimal medical therapy (OMT) relative to patients with OMT alone. Methods: A two-component model was used to analyze lifetime costs and quality-adjusted life-years (QALYs) from a healthcare perspective. Clinical inputs were mostly obtained from meta-analysis of landmark trials. All cost-related data, risk of non-cardiovascular death and readmission rate were based on Thai HF data. Costs and QALYs were discounted at 3%. Findings were reported as an incremental cost-effectiveness ratio (ICER). A variety of sensitivity analyses were also performed. Results: CRT plus OMT costs more than OMT (123,279 vs 11,165 THB or 3,972.90 vs 359.81 USD), and is more effective (3.57 QALYs vs 2.49 QALYs), yielding an ICER of 104,325 THB per QALY (3,362.07 USD per QALY). CRT was cost-effective at the Thai willingness to pay threshold of 160,000 THB per QALY (5,156.30 USD per QALY). The results were sensitive to cost of CRT maintenance. Conclusion: The use of CRT was associated with a cost-effectiveness ratio below generally accepted benchmarks for therapeutic interventions of 160,000 THB per QALY (5,156.30 USD per QALY). This suggests that the clinical benefits of CRT can be achieved at a reasonable cost in Thai HF patients.
引用
收藏
页码:579 / 588
页数:10
相关论文
共 37 条
[31]  
Permsuwan Unchalee, 2014, Journal of the Medical Association of Thailand, V97, pS50
[32]   2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [J].
Ponikowski, Piotr ;
Voors, Adriaan A. ;
Anker, Stefan D. ;
Bueno, Hector ;
Cleland, John G. F. ;
Coats, Andrew J. S. ;
Falk, Volkmar ;
Ramon Gonzalez-Juanatey, Jose ;
Harjola, Veli-Pekka ;
Jankowska, Ewa A. ;
Jessup, Mariell ;
Linde, Cecilia ;
Nihoyannopoulos, Petros ;
Parissis, John T. ;
Pieske, Burkert ;
Riley, Jillian P. ;
Rosano, Giuseppe M. C. ;
Ruilope, Luis M. ;
Ruschitzka, Frank ;
Rutten, Frans H. ;
van der Meer, Peter .
EUROPEAN HEART JOURNAL, 2016, 37 (27) :2129-U130
[33]   Heart failure across Asia: Same healthcare burden but differences in organization of care [J].
Reyes, Eugenio B. ;
Ha, Jong-Won ;
Firdaus, Isman ;
Ghazi, Azmee Mohd ;
Phrommintikul, Arintaya ;
Sim, David ;
Quynh Nga Vu ;
Siu, Chung Wah ;
Yin, Wei-Hsian ;
Cowie, Martin R. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 :163-167
[34]   The health services burden of heart failure: an analysis using linked population health data-sets [J].
Robertson, Jane ;
McElduff, Patrick ;
Pearson, Sallie-Anne ;
Henry, David A. ;
Inder, Kerry J. ;
Attia, John R. .
BMC HEALTH SERVICES RESEARCH, 2012, 12
[35]   Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data [J].
Shah, Dhvani ;
Lu, Xiaoxiao ;
Paly, Victoria F. ;
Tsintzos, Stelios, I ;
May, Damian M. .
JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) :690-697
[36]   Heart failure as a general pandemic in Asia [J].
Shimokawa, Hiroaki ;
Miura, Masanobu ;
Nochioka, Kotaro ;
Sakata, Yasuhiko .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (09) :884-892
[37]   Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study [J].
Teng, Tiew-Hwa K. ;
Tromp, Jasper ;
Tay, Wan Ting ;
Anand, Inder ;
Ouwerkerk, Wouter ;
Chopra, Vijay ;
Wander, Gurpreet S. ;
Yap, Jonathan J. L. ;
MacDonald, Michael R. ;
Xu, Chang Fen ;
Chia, Yvonne M. F. ;
Shimizu, Wataru ;
Richards, A. Mark ;
Voors, Adriaan ;
Lam, Carolyn S. P. .
LANCET GLOBAL HEALTH, 2018, 6 (09) :E1008-E1018